Abiopharma

🔍 Kirkland Scott D (Executive)

Company: ECOLAB INC. (ECL)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Acquired 3,972 shares of Common Stock at $117.73 per share (Direct)
  Date: 2026-07-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 20,881.41 | transaction_form_type: 4
• Sold 3,357 shares of Common Stock at $276.96 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 17,524.41 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-30 | Code: H | nature_of_ownership: By Ecolab Savings Plan | shares_owned_after: 1,477.40 | Footnotes: F1
• Sold 3,972 shares of Employee Stock Option (Right to Buy) at $117.73 per share (Derivative)
  Date: 2026-07-30 | Code: M | Expires: 2026-12-07 | Exercise: 2017-12-07 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Number of UNITS in the Ecolab Stock Fund of the Ecolab Savings Plan (401(k) Plan) as of June 30, 2026. Includes 21.817 UNITS acquired since the reporting person's last report. (The 1,477.401 UNITS are the equivalent of approximately 2,710 SHARES of the issuer's Common Stock.)
• F2: Option granted under the Ecolab Inc. 2010 Stock Incentive Plan. The option became or becomes exercisable, on a cumulative basis, as to one-third of the option shares (excluding any fractional portion less than one share), on each of the first and second anniversaries of the date of grant and as to the remaining option shares on the third anniversary of the date of grant. The date listed is the first anniversary of the date of grant.